MRG-229

N/A

Report date: 2022/03/17 13:20:54
NME

Base Information

Drug NameMRG-229
Drug Alias NameMRG-229
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionMicroRNA 29 replacements
TargetsNot applicable
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A